Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Circulation
|
May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction
E J Topol, R M Califf, B S George, et al.
Circulation
|
February 1, 1989
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction
E J Topol, B S George, D J Kereiakes, et al.
Thrombosis and Haemostasis
|
March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction
D C Sane, D C Stump, E J Topol, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
March 29, 2000
Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy
C P Semba, C W Bakal, K A Calis, et al.
Journal of the American College of Cardiology
|
October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group
E J Topol, S G Ellis, R M Califf, et al.
Circulation
|
January 1, 1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group
D C Sane, D C Stump, E J Topol, et al.
The New England Journal of Medicine
|
September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia
R G Strauss, J E Connett, R P Gale, et al.
American Heart Journal
|
February 7, 1998
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial
R P Tracy, N S Kleiman, B Thompson, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Circulation
|
May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction
E J Topol, R M Califf, B S George, et al.
Circulation
|
February 1, 1989
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction
E J Topol, B S George, D J Kereiakes, et al.
Thrombosis and Haemostasis
|
March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction
D C Sane, D C Stump, E J Topol, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
March 29, 2000
Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy
C P Semba, C W Bakal, K A Calis, et al.
Journal of the American College of Cardiology
|
October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group
E J Topol, S G Ellis, R M Califf, et al.
Circulation
|
January 1, 1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group
D C Sane, D C Stump, E J Topol, et al.
The New England Journal of Medicine
|
September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia
R G Strauss, J E Connett, R P Gale, et al.
American Heart Journal
|
February 7, 1998
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial
R P Tracy, N S Kleiman, B Thompson, et al.
Page
of 6